J R Hecht Selected Research

trimetrexate glucuronate (NeuTrexin)

4/2002

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J R Hecht Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 12/2000
2	Stomach Neoplasms (Stomach Cancer) 09/2011 - 12/2000
1	Back Pain (Backache) 01/2018
1	Constipation 01/2018
1	Fatigue 01/2018
1	Nausea 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Adenocarcinoma 09/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2002
1	Carcinoma (Carcinomatosis) 12/2000

Drug/Important Bio-Agent (IBA)

2	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 04/2002
1	ontuxizumabIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2011
1	trimetrexate glucuronate (NeuTrexin)FDA Link 04/2002
1	Trimetrexate (JB11)FDA Link 04/2002
1	Folic Acid AntagonistsIBA 04/2002

Therapy/Procedure

1	Therapeutics 12/2000